Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Income from Continuing Operations (2022 - 2025)

Envoy Medical's Income from Continuing Operations history spans 4 years, with the latest figure at 6385000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 6385000.0 for Q4 2025, down 29.43% from a year ago — trailing twelve months through Dec 2025 was 23860000.0 (down 18.87% YoY), and the annual figure for FY2025 was 23860000.0, down 18.87%.
  • Income from Continuing Operations for Q4 2025 was 6385000.0 at Envoy Medical, down from 6179000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 12461381.0 in Q1 2022 to a low of 6723000.0 in Q4 2023.
  • The 4-year median for Income from Continuing Operations is 4926500.0 (2024), against an average of 2201739.56.
  • Peak annual rise in Income from Continuing Operations hit 26.63% in 2024, while the deepest fall reached 785.52% in 2024.
  • Year by year, Income from Continuing Operations stood at 2008739.0 in 2022, then crashed by 234.69% to 6723000.0 in 2023, then increased by 26.63% to 4933000.0 in 2024, then decreased by 29.43% to 6385000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 6385000.0, 6179000.0, and 5694000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.